As of 2025-10-13, the Relative Valuation of Abbott Laboratories (ABT) is 219.94 USD. This relative valuation is based on P/E multiples. With the latest stock price at 132.57 USD, the upside of Abbott Laboratories based on Relative Valuation is 65.9%.
The range of the Relative Valuation is 127.94 - 348.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.5x - 43.4x | 37.9x |
| Forward P/E multiples | 30.9x - 34.1x | 32.7x |
| Fair Price | 127.94 - 348.42 | 219.94 |
| Upside | -3.5% - 162.8% | 65.9% |
| Date | P/E |
| 2025-10-10 | 16.51 |
| 2025-10-09 | 16.60 |
| 2025-10-08 | 16.72 |
| 2025-10-07 | 16.56 |
| 2025-10-06 | 16.65 |
| 2025-10-03 | 16.76 |
| 2025-10-02 | 16.56 |
| 2025-10-01 | 16.62 |
| 2025-09-30 | 16.68 |
| 2025-09-29 | 16.57 |
| 2025-09-26 | 16.63 |
| 2025-09-25 | 16.60 |
| 2025-09-24 | 16.67 |
| 2025-09-23 | 16.92 |
| 2025-09-22 | 17.01 |
| 2025-09-19 | 16.94 |
| 2025-09-18 | 16.75 |
| 2025-09-17 | 16.70 |
| 2025-09-16 | 16.53 |
| 2025-09-15 | 16.35 |
| 2025-09-12 | 16.65 |
| 2025-09-11 | 16.52 |
| 2025-09-10 | 16.11 |
| 2025-09-09 | 16.43 |
| 2025-09-08 | 16.46 |
| 2025-09-05 | 16.55 |
| 2025-09-04 | 16.54 |
| 2025-09-03 | 16.46 |
| 2025-09-02 | 16.37 |
| 2025-08-29 | 16.52 |
| 2025-08-28 | 16.36 |
| 2025-08-27 | 16.37 |
| 2025-08-26 | 16.38 |
| 2025-08-25 | 16.42 |
| 2025-08-22 | 16.51 |
| 2025-08-21 | 16.43 |
| 2025-08-20 | 16.49 |
| 2025-08-19 | 16.34 |
| 2025-08-18 | 16.22 |
| 2025-08-15 | 16.40 |
| 2025-08-14 | 16.10 |
| 2025-08-13 | 16.11 |
| 2025-08-12 | 16.31 |
| 2025-08-11 | 16.36 |
| 2025-08-08 | 16.72 |
| 2025-08-07 | 16.44 |
| 2025-08-06 | 16.30 |
| 2025-08-05 | 16.27 |
| 2025-08-04 | 16.18 |
| 2025-08-01 | 15.85 |